These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35677337)

  • 21. Profiling cognitive and neuropsychiatric heterogeneity in Parkinson's disease.
    van Balkom TD; Vriend C; Berendse HW; Foncke EM; van der Werf YD; van den Heuvel OA; Klein M
    Parkinsonism Relat Disord; 2016 Jul; 28():130-6. PubMed ID: 27215393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life.
    Huang X; Ng SY; Chia NS; Setiawan F; Tay KY; Au WL; Tan EK; Tan LC
    Eur J Neurol; 2019 Mar; 26(3):400-406. PubMed ID: 30175887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-year clinical progression in focal and diffuse subtypes of Parkinson's disease.
    Johansson ME; van Lier NM; Kessels RPC; Bloem BR; Helmich RC
    NPJ Parkinsons Dis; 2023 Feb; 9(1):29. PubMed ID: 36806285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between motor subtypes and alexithymia in de novo Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Lucetti C; Del Dotto P; Tognoni G; Ceravolo R; Bonuccelli U
    J Neurol; 2011 Jun; 258(6):1042-5. PubMed ID: 21188407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis.
    Hähnel T; Raschka T; Sapienza S; Klucken J; Glaab E; Corvol JC; Falkenburger BH; Fröhlich H
    NPJ Parkinsons Dis; 2024 May; 10(1):95. PubMed ID: 38698004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtypes of Parkinson's disease: state of the field and future directions.
    Marras C
    Curr Opin Neurol; 2015 Aug; 28(4):382-6. PubMed ID: 26110797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-predictor modeling for predicting early Parkinson's disease and non-motor symptoms progression.
    Dou K; Ma J; Zhang X; Shi W; Tao M; Xie A
    Front Aging Neurosci; 2022; 14():977985. PubMed ID: 36092799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical subtypes of Parkinson's disease.
    van Rooden SM; Colas F; Martínez-Martín P; Visser M; Verbaan D; Marinus J; Chaudhuri RK; Kok JN; van Hilten JJ
    Mov Disord; 2011 Jan; 26(1):51-8. PubMed ID: 21322019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts.
    Lawton M; Tan MM; Ben-Shlomo Y; Baig F; Barber T; Klein JC; Evetts SG; Millin S; Malek N; Grosset K; Barker RA; Williams N; Burn DJ; Foltynie T; Morris HR; Wood N; Grosset DG; Hu MT
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(9):952-9. PubMed ID: 35732412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data.
    Brendel M; Su C; Hou Y; Henchcliffe C; Wang F
    NPJ Parkinsons Dis; 2021 Sep; 7(1):83. PubMed ID: 34535682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
    Burn DJ; Rowan EN; Allan LM; Molloy S; O'Brien JT; McKeith IG
    J Neurol Neurosurg Psychiatry; 2006 May; 77(5):585-9. PubMed ID: 16614017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Motor Symptoms of the Postural Instability and Gait Difficulty Subtype in De Novo Parkinson's Disease Patients: A Cross-Sectional Study in a Single Center.
    Ren J; Hua P; Pan C; Li Y; Zhang L; Zhang W; Xu P; Zhang M; Liu W
    Neuropsychiatr Dis Treat; 2020; 16():2605-2612. PubMed ID: 33173298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Parkinson's disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering.
    Rodriguez-Sanchez F; Rodriguez-Blazquez C; Bielza C; Larrañaga P; Weintraub D; Martinez-Martin P; Rizos A; Schrag A; Chaudhuri KR
    Sci Rep; 2021 Dec; 11(1):23645. PubMed ID: 34880345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing and validating Parkinson's disease subtypes and their motor and cognitive progression.
    Lawton M; Ben-Shlomo Y; May MT; Baig F; Barber TR; Klein JC; Swallow DMA; Malek N; Grosset KA; Bajaj N; Barker RA; Williams N; Burn DJ; Foltynie T; Morris HR; Wood NW; Grosset DG; Hu MTM
    J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1279-1287. PubMed ID: 30464029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity among patients with Parkinson's disease: cluster analysis and genetic association.
    Ma LY; Chan P; Gu ZQ; Li FF; Feng T
    J Neurol Sci; 2015 Apr; 351(1-2):41-45. PubMed ID: 25732803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Parkinson's disease subtypes with distinct brain atrophy progression and its association with clinical progression.
    Pan G; Jiang Y; Zhang W; Zhang X; Wang L; Cheng W
    Psychoradiology; 2024; 4():kkae002. PubMed ID: 38666137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replication and reliability of Parkinson's disease clinical subtypes.
    Cash TV; Lessov-Schlaggar CN; Foster ER; Myers PS; Jackson JJ; Maiti B; Kotzbauer PT; Perlmutter JS; Campbell MC
    Parkinsonism Relat Disord; 2024 Jul; 124():107016. PubMed ID: 38838453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychiatric profile of motor subtypes of de novo drug-naïve Parkinson's disease patients.
    Assogna F; Pellicano C; Cravello L; Savini C; Pierantozzi M; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G; Stefani A
    Brain Behav; 2018 Oct; 8(10):e01094. PubMed ID: 30160376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.